Hempstract, Inc. (HPST) Research

Operating across the United States, Hempstract, Inc. develops and supplies products centered around cannabidiol (CBD) and cannabigerol (CBG). Its catalog features CBD in isolate powder form, alongside various distillate oils. The enterprise adopted the Hempstract, Inc. moniker in November 2020, having previously been known as Riverdale Oil and Gas Corporation. This firm maintains its principal office in Warden, Washington.

Market snapshot

Symbol
HPST
Price
$0.03
Day change
+2.04%
Market cap
$54.8M
P/E ratio
-10.14x
52-week range
0.0019-0.0448
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Antisense Therapeutics Limited (ATHJF)
  • Biofrontera AG (BFFTF)
  • Chill Brands Group PLC (CHBRF)
  • MakingORG, Inc. (CQCQ)
  • Generation Hemp, Inc. (GENH)
  • TPCO Holding Corp. (GRAMF)
  • IBEX Technologies Inc. (IBXNF)
  • Mauna Kea Technologies S.A. (MKEAF)

Open Hempstract, Inc. (HPST) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.